Early cerebral manifestations in a young female with Fabry disease with skewed X-inactivation.
M G Bouwman, S M Rombach, G E Linthorst, B J H M Poorthuis, R H Lekanne Deprez, J M F G Aerts, F A Wijburg
Index: Clin. Genet. 80(5) , 500-2, (2011)
Full Text: HTML
Abstract
Related Compounds
Related Articles:
LC–MS/MS analysis of plasma lyso-Gb3 in Fabry disease
2012-12-24
[Clin. Chim. Acta 414 , 273-80, (2012)]
A metabolomic study reveals novel plasma lyso-Gb3 analogs as Fabry disease biomarkers.
2013-01-01
[Curr. Med. Chem. 20(2) , 280-8, (2013)]
In vivo tumor targeting using a novel intestinal pathogen-based delivery approach.
2006-07-15
[Cancer Res. 66(14) , 7230-6, (2006)]
Plasma globotriaosylsphingosine as a biomarker of Fabry disease.
2010-07-01
[Mol. Genet. Metab. 100(3) , 257-61, (2010)]
Quantification of the Fabry marker lysoGb3 in human plasma by tandem mass spectrometry.
2012-02-01
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 883-884 , 128-35, (2012)]